REG - Target H'care REIT - Net Asset Value, Corporate Update & Dividend

Target Healthcare ReitAnnouncement

03/05/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230503:nRSC1821Ya&default-theme=true

RNS Number : 1821Y  Target Healthcare REIT PLC  03 May 2023

3 May 2023

 

Target Healthcare REIT plc and its subsidiaries

 

("Target Healthcare" or "the Group")

 

Net Asset Value, update on corporate activity and dividend declaration

 

Target Healthcare (LSE: THRL), the UK listed specialist investor in modern,
purpose-built care homes, announces its unaudited quarterly Net Asset Value
('NAV') as at 31 March 2023, together with an update on corporate activity,
and declares its third interim dividend for the year ending 30 June 2023.

 

Corporate activity highlights

 

NTA and earnings growth, the latter fully covering rebased dividend level;
stable balance sheet with conservative LTV and hedged interest costs:

 

·     EPRA Net Tangible Assets ('NTA') per share increased to 103.4 pence
(31 December 2022: 103.0 pence), primarily driven by like-for-like valuation
uplift from inflation-linked rent reviews and reflecting minimal yield shift

·      Adjusted EPRA EPS for the quarter of 1.5 pence per share, fully
covering dividend to be paid in respect of the quarter of 1.4 pence per share

·      Portfolio EPRA "topped-up" net initial yield of 6.21% (31
December 2022: 6.22%)

·      NAV total return of 2.1% for the quarter (based on EPRA NTA and
including payment of dividend)

·      Net Loan to Value of 23.8% (31 December 2022: 25.1%)

·     Weighted average term to expiry on the Group's total committed
loan facilities of 6.5 years (31 December 2022: 6.7 years) with an earliest
maturity of November 2025. Interest costs hedged on 100% of drawn debt to the
relevant facility maturity date

·      Overall capital available currently £62 million, net of the
Group's commitments on the four development assets

 

Disposals and re-tenanting activities optimising portfolio to benefit from
demand tailwinds and positive outlook for private-pay market; portfolio
valuation evidenced by £22m of disposals ahead of carry value; further rental
growth and rent collection improvement:

 

·      Diversified portfolio of 97 assets let to 32 tenants and valued
at £855.7 million (31 December 2022: £867.7 million); on a like-for-like
basis the portfolio valuation increased by 0.5%

·    Disposal of four properties in Northern Ireland for a net price
above their blended book value as at 30 June 2022, crystallising an annualised
ungeared IRR in excess of 10% over the period of ownership

·      Excluding recent disposals (2.8% decrease), the contracted rent
roll increased 0.8%, from 22 inflation-linked upwards-only rent reviews, at an
average uplift of 3.9%

·     Weighted average unexpired lease term of 26.8 years remains one of
the longest in the listed real estate sector (31 December 2022: 26.8 years),
with the disposal of four shorter-duration leases offsetting the effect of the
passage of time on the remaining portfolio

·      High quality, modern and sustainable real estate portfolio:

o  94% of the portfolio is A or B EPC rated, and currently compliant with the
minimum energy efficiency standards anticipated to apply from 2030

o  Leading Positive social impact from sector-leading real estate standards:
97% wet-rooms; generous 47 sqm space per resident; sustainable rent of £184
per sqm

·    Rent collection of 97% (31 December 2022: 96%; 30 September 2022:
96%; 30 June 2022: 94%) as overall tenant profitability responds to the
improved trading conditions across prime care homes, and in response to the
completion of portfolio management initiatives

 

Kenneth MacKenzie, CEO of Target Fund Managers, commented:

 

"The long-term stability of prime UK care homes as an investment class
continues to be demonstrated. Unlike many other parts of the sector, not only
are valuation levels being underpinned by both occupier and investor demand,
but we are also seeing rental quality backed by improving profitability
trends. Rent cover, a key profitability metric, has improved to 1.5x for the
most recent quarter we have data for. This compares well to pre-pandemic norms
despite being achieved at lower levels of underlying resident occupancy,
currently 84%. We anticipate further tenant profitability growth as occupancy
closes in on the 90% generally experienced prior to the pandemic, which will
further support valuations. The real estate standards fundamental to our
strategy enable our tenants to attract private-fee paying residents at fee
levels where they can increase staff pay and reinvest in their business.

 

"The recent announcement to rebase our dividend in line with current earnings
was recognition of the higher interest rate environment limiting our ability
to grow earnings through acquisitions at this time, as investment yields have
remained relatively low for the prime UK care homes we invest in. We retain a
strong conviction that improving portfolio performance, strong demographic
tailwinds and our embedded inflation-linked rental growth will drive long-term
sustainable returns."

 

Net Total Assets

 

The Group's unaudited EPRA NTA per share as at 31 March 2023 was 103.4 pence.
The total return for the quarter based on EPRA NTA was 2.1%.

 

A balance sheet summary and an analysis of the movement in the EPRA NTA over
the quarter is presented at the end of this announcement in the Appendix.

 

Corporate Update

 

Portfolio performance

 

As at 31 March 2023, the Group's portfolio was valued at £855.7 million and
comprised 97 properties, consisting of 93 operational care homes and four
pre-let sites, which are being developed through capped forward funding
commitments with established development partners.

 

The portfolio value decreased by 1.4% over the quarter, comprising:

·     a 0.5% increase in the like-for-like operational portfolio,
reflecting a 0.8% increase from inflation-linked rent reviews and asset
management activity, offset by a marginal 0.3% decrease driven by net outward
yield shift on a limited number of specific assets

·     a 2.4% decrease from the sale of four properties located in Northern
Ireland, of which sales proceeds represented a property value decrease of 2.5%
and the gain relative to the external valuation of the properties at 31
December 2022 was 0.1%

·      a 0.5% increase from capital expenditure, mainly associated with
the four development properties

 

Contractual rental income decreased by 2.0% over the quarter, comprising:

·      a 0.8% like-for-like increase from 22 inflation-linked
upwards-only rent reviews, with an average uplift of 3.9%; and

·      a 2.8% decrease from the sale of four properties located in
Northern Ireland

 

The portfolio's weighted average unexpired lease term was 26.8 years (31
December 2022: 26.8 years).

 

The portfolio had an EPRA "topped-up" net initial yield of 6.21% based on an
annualised contractual rent of £55.9 million. The portfolio's EPRA net
initial yield was 6.04% with two assets in rent-free periods.

 

Acquisitions and other asset management

 

As previously disclosed by the Group, during the quarter the following
transactions and asset management initiatives were completed:

 

·    The sale of four care homes in Northern Ireland, representing c. 2.5%
of the Group's overall portfolio value. The disposals represent a full exit
from the Northern Irish market and form part of the Group's wider capital
recycling and asset management strategy. The blended disposal price is
supportive of the Group's valuations, being ahead of carrying value at both 30
June 2022 (the Group's last financial year-end) and 31 December 2022, and
results in an annualised ungeared IRR in excess of 10% over the period of
ownership.

·    The acquisition of a development site near Malvern, Worcestershire,
following the receipt of the required planning consent for the construction of
a 60-bed care home. Consistent with the Group's standard approach, the home is
pre-let to an existing tenant and has in place a capped development agreement
which is itself underpinned by a fixed price construction contract. The lease
includes green provisions such as energy-related data collection, per the
Group's standard lease.

·    Completion of the process to re-tenant one home, which will alleviate
cashflow pressures for a tenant, allowing a return to a fully rent-paying
position on its three remaining homes. The contractual rent for the incoming
tenant will remain the same.

 

 

Debt facilities and swap arrangements

 

As at 31 March 2023, the Group's total borrowings were £230 million,
representing a net LTV of 23.8% (total gross debt less cash, as a proportion
of gross property value). The Group's weighted average cost on its drawn debt,
inclusive of amortisation of loan arrangement costs, was 3.70% (31 December
2022: 3.79%). This excludes the amortisation of the cost of the interest rate
cap given the full cost has already been deducted in calculating the EPRA NTA.
The decrease in the Group's weighted average cost on its drawn debt over the
quarter was due to the partial repayment of the Group's revolving credit
facilities following the sale of the Northern Ireland properties.

 

The £230 million of drawn debt is fully hedged to further increases in
interest rates. £150 million has been fixed for a weighted average term of
10.9 years with a weighted average interest rate excluding the amortisation of
arrangement fees of 3.18%. £30 million of the Group's bank facilities have
been fixed at 2.48% for 2.6 years through an interest rate swap and the
remaining £50 million of the Group's drawn revolving credit facilities have
interest rates capped via a 3% SONIA cap, also for 2.6 years. The Group has
access to a further £90 million of committed, but undrawn, revolving credit
facilities.

 

At 31 March 2023, the weighted average term to expiry on the Group's total
committed loan facilities was 6.5 years (31 December 2022: 6.7 years).

 

Dividends in the period

 

The Group paid its second interim dividend for the year ending 30 June 2023,
in respect of the period from 1 October 2022 to 31 December 2022, of 1.69
pence per share, on 24 February 2023 to shareholders on the register on
10 February 2023. This distribution was comprised wholly of a property income
distribution (PID).

 

The Company announced on 27 March 2023 that increases in the marginal rate of
financing and lower net initial yields available on assets that meet the
Group's strict investment criteria had resulted in Board concluding that the
most appropriate response was to rebase the target annual dividend level to
5.60 pence per share to reflect the Group's current recurring earnings. The
Board's priority is to offer an attractive dividend to shareholders which (i)
will be fully covered by earnings (ii) allows annual growth and (iii) fully
contributes to an attractive level of total return.

 

Announcement of third interim dividend

 

The Company today declares its third interim dividend for the year ending 30
June 2023, in respect of the period from 1 January 2023 to 31 March 2023, of
1.40 pence per share as detailed in the schedule below:

 

Interim Property Income Distribution (PID):     1.40 pence per share

Interim ordinary
dividend:
nil

 

 Ex-Dividend Date:  11 May 2023
 Record Date:       12 May 2023
 Payment Date:      26 May 2023

 

The dividend reflects an annualised payment of 5.60 pence per share and a
dividend yield of 7.4% based on the 2 May 2023 closing share price of 75.7
pence.

 

 

The Company had 620,237,346 ordinary shares in issue at 31 March 2023 and has
not issued or bought back any shares since that date.

 

Shareholders entitled to elect to receive distributions without deduction for
withholding tax may complete the declaration form which is available on
request from the Company through the contact details provided on its website
www.targethealthcarereit.co.uk (http://www.targethealthcarereit.co.uk) , or
from the Company's registrar. Shareholders who qualify for gross payments are,
principally, UK resident companies, certain UK public bodies, UK charities, UK
pension schemes and the managers of ISAs, PEPs and Child Trust Funds, in each
case subject to certain conditions. Individuals and non-UK residents do not
qualify for gross payments of distributions and should not complete the
declaration form.

LEI: 213800RXPY9WULUSBC04

 

ENDS

 

 

 

Enquiries:

 

 

 Target Fund Managers Limited    Tel: 01786 845 912
 Kenneth MacKenzie
 Gordon Bland

 Stifel Nicolaus Europe Limited  Tel: 020 7710 7600
 Mark Young
 Catriona Neville

 FTI Consulting                  Tel: 020 7710 7600
 Dido Laurimore                  TargetHealthcare@fticonsulting.com
 Richard Gotla

Notes to editors:

UK listed Target Healthcare REIT plc (THRL) is an externally managed Real
Estate Investment Trust which provides shareholders with an attractive level
of income, together with the potential for capital and income growth, from
investing in a diversified portfolio of modern, purpose-built care homes.

The Group's portfolio at 31 March 2023 comprised 97 assets let to 32 tenants
with a total value of £855.7 million.

The Group invests in modern, purpose-built care homes that are let to high
quality tenants who demonstrate strong operational capabilities and a strong
care ethos. The Group builds collaborative, supportive relationships with each
of its tenants as it believes working in this way helps raise standards of
care and helps its tenants build sustainable businesses. In turn, that helps
the Group deliver stable returns to its investors.

Important information

 

The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the UK version of the Market
Abuse Regulations (EU) No. 596/2014, which is part of UK law by virtue of the
European Union (Withdrawal) Act 2018, as amended. Upon the publication of this
announcement via Regulatory Information Service, this inside information is
now considered to be in the public domain.

APPENDIX

 

1.     Analysis of movement in EPRA NTA

 

The following table provides an analysis of the movement in the unaudited EPRA
NTA per share for the period from 1 January 2023 to 31 March 2023:

 

                                                                   Pence per share
 EPRA NTA per share as at 31 December 2022                                           103.0

 Revaluation gains / (losses) on investment properties             0.7
 Revaluation gains / (losses) on assets under construction^        (0.2)
 Revaluation gains / (losses) on investment properties realised    0.1
 Movement in revenue reserve                                       1.5
 Second interim dividend payment for the year ending 30 June 2023  (1.7)
 EPRA NTA per share as at 31 March 2023                            103.4
 Percentage change in the quarter                                  0.4%

 

The EPRA Best Practices Recommendations Guidelines state that companies should
publish a set of three NAV metrics. The full set of EPRA NAV metrics are
published in the Group's Annual Report. The Company intends to continue to
announce the EPRA NTA on a quarterly basis.

 

At 31 March 2023, due to the valuation ascribed to the Group's interest rate
derivative contracts used to hedge its exposure to variable interest rates,
which are excluded from the calculation of the EPRA NTA, the unaudited NAV
calculated under International Financial Reporting Standards was 104.2 pence
per share.

 

^Consistent with standard valuation practice for assets under construction,
the carrying value of these assets is calculated by the valuer through
application of a discount to accumulated costs to date. This discount varies
depending on factors such as the remaining development time. As the asset
progresses towards completion, the discount that has been applied is unwound.

 

 2.     Summary balance sheet (unaudited)

                                      Mar-23        Dec-22        Sep-22        Jun-22
                                      £m            £m            £m            £m
 Property portfolio*                  855.7         867.7         913.7         911.6
 Cash                                 26.4          21.8          19.6          34.5
 Net current assets / (liabilities)*  (10.5)        (10.4)        (15.2)        (14.8)
 Bank loans                           (230.0)       (240.0)       (223.0)       (234.8)
 Net assets                           641.6         639.1         695.1         696.5

 EPRA NTA per share (pence)           103.4         103.0         112.1         112.3

 

*Properties within the portfolio are stated at the market value provided by
the external valuer and the IFRS effects of fixed/guaranteed minimum rent
reviews are not reflected.

 

The next quarterly valuation of the property portfolio will be conducted by
Colliers International Healthcare Property Consultants Limited during July
2023 and the unaudited EPRA NTA per share as at 30 June 2023 is expected to be
announced in July 2023.

 

3.     EPRA NIY profiles and unwind of rent-free periods

 

The Group currently has two assets with rent-free periods. As these unwind,
assuming no other changes including inter alia the portfolio valuation or
rental profile, the EPRA yield profiles for the portfolio will be as follows:

                         31 March  30 June  30 Sept  31 Dec  31 March  30 June

                         2023      2023     2023     2023    2024      2024
 EPRA topped-up NIY      6.21%     6.21%    6.21%    6.21%   6.21%     6.21%
 EPRA NIY                6.04%     6.04%    6.04%    6.13%   6.17%     6.21%
 Contractual rent (£m)   55.9      55.9     55.9     55.9    55.9      55.9
 Passing rent (£m)       54.4      54.4     54.4     55.2    55.6      55.9

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCNKBBKOBKDPPK